kihe 2020 08 aipm

pediatria 3

AIPM in the Republic of Kazakhstan would like to invite all participants of the medical drugs distri

code of ethicsAIPM in the Republic of Kazakhstan would like to invite all participants of the medical drugs distribution chain to sign the Code of Ethics for the Promotion of Medicines. This is an important step towards establishing a transparent competitive environment on the Kazakh pharmaceutical market.
Both pharmaceutical companies and doctors prescribing medicines, as well as government employees making decision on procurement thereof can sign the Code of Ethics. Commitment to ethical standards in this field is going to be an important evidence of the fact that in your activities you are being guided by the interests of patients only, rather than by your self-interest. 
 
The AIPM Code of Ethics in the Republic of Kazakhstan was drafted based the international marketing practices codes, with a view to the legislation of Kazakhstan.

READ FULL VERSION OF THE CODE OF ETHICS FOR THE PROMOTION OF MEDICINES

JOIN

News and Events

Russia Will Register Drug only in Accordance with EAEU Rules since 2021

Russia Will Register Drug only in Accordance with EAEU Rules since 2021

09 January 2020 - 83 Views

The Ministry of Industry and Trade of the Russian Federation proposes from January 1, 2021 to register new drugs for medical use only within the framework of the rules of the Eurasian Economic Union, the press service of the

...
Gilead Filgotinib Proved Successful in Trial Evaluating Efficacy and Safety

Gilead Filgotinib Proved Successful in Trial Evaluating Efficacy and Safety

12 December 2019 - 102 Views

Gilead has announced that its investigational rheumatoid arthritis (RA) drug, filgotinib, has proved successful in a trial evaluating its efficacy and safety when treating moderately-to-severely active versions of the

...
FDA Approved New Diagnostic Test Based on Bacterial Viability

FDA Approved New Diagnostic Test Based on Bacterial Viability

12 December 2019 - 111 Views

The U.S. Food and Drug Administration authorized marketing of a new diagnostic test based on bacterial viability and novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacterial

...
Novartis to Submit 80 Major Marketing Applications for its Drugs from 2020 to 2022

Novartis to Submit 80 Major Marketing Applications for its Drugs from 2020 to 2022

12 December 2019 - 109 Views

Novartis said Thursday ahead of a meeting with analysts and investors that it expects to submit more than 80 major marketing applications for its drugs from 2020 to 2022 in the US, Europe, Japan and China. CEO Vas Narasimhan

...
AbbVie Announced Collaboration with Scripps Research to Develop New Therapies

AbbVie Announced Collaboration with Scripps Research to Develop New Therapies

12 December 2019 - 98 Views

AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration to develop new therapies for a range of

...
Sanofi Exits Diabetes and Cardiovascular Research

Sanofi Exits Diabetes and Cardiovascular Research

12 December 2019 - 112 Views

Ahead of a presentation to the financial community on December 10, Sanofi announced Monday that it is halting research into diabetes and cardiovascular (CV) treatments, and will not pursue plans to launch the

...

Kazakhstan legislation

The Code of the Republic of Kazakhstan dated on September 18, 2009 No 193-IV

On public health and health care system (Unofficial translation)

Order of the Minister of Health and Social Development of the Republic of Kazakhstan No. 10 dated January 14, 2015

On Amendments to the Order of the Minister of Health of the Republic of Kazakhstan dated November 18, 2009 No. 736 “On Approval of the Medical Agents, Medical Products and Medical Equipment Examination Procedures”